Impact of paraoxon followed by acetylcholinesterase reactivator HI-6 on gastric myoelectric activity in experimental pigs

Neuroendocrinology Letters

Volumn 34, Issue SUPPL. 2, 2013, Pages 79-83

  Bureš, Jan ^a   Květina, Jaroslav ^a   Pavlík, Michal ^b   Kuneš, Martin ^a   Kopáčová, Marcela ^a   Rejchrt, Stanislav ^a   Jun, Daniel ^c   Hrabinová, Martina ^c   Kuča, Kamil ^a   Tachecí, Ilja ^a  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^b UNIVERSITY OF DEFENCE   (Czech Republic)

^c UNIVERSITY OF DEFENCE   (Czech Republic)

Author keywords

Acetylcholinesterase reactivators; Electrogastrography; Experimental animals; HI 6 dimethansulphonate; Paraoxon

Indexed keywords

1 (4 CARBAMOYLPYRIDINIO) 1' (2 HYDROXYIMINOMETHYLPYRIDINIO)DIMETHYL ETHER; PARAOXON;

AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ELECTROGASTROGRAPH; ELECTROGASTROGRAPHY; EXPERIMENTAL PIG; FEMALE; HEART RATE; MYOELECTRICITY; NONHUMAN; OXYGEN SATURATION; STOMACH; STOMACH FUNCTION; VITAL SIGN;

ANIMALS; CHOLINESTERASE REACTIVATORS; ELECTROMYOGRAPHY; FEMALE; HEART RATE; INJECTIONS, INTRAMUSCULAR; MODELS, ANIMAL; OXIMES; PARAOXON; PYRIDINIUM COMPOUNDS; STOMACH; SWINE;

EID: 84893953134     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Amitai G, Rabinovitz I, Zomber G, Chen R, Cohen G, Adani R, et al (1995). Bisquaternary oximes as antidotes against tabun and soman poisoning. Antidotal efficacy in relation to cholinesterase reactivation. In: Enzymes of the Cholinesterase Family (ed. DM Quin et al.). New York: Plenum Press.
2. Bajgar J (2004) Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv Clin Chem. 38: 151-216.
3. Bajgar J, Fusek J, Kuca K, Bartosova L, Jun D (2007). Treatment of organophosphate intoxication using cholinesterase reactivators: facts and fiction. Mini Rev Med Chem. 7: 461-466. (Pubitemid 46845793)
4. Bajgar J, Fusek J, Kassa J, Kuca K, Jun D (2009). Chemical aspects of pharmacological prophylaxis against nerve agent poisoning. Curr Med Chem. 16: 2977-2986.
5. Bajgar J (2010). Optimal choice of acetylcholinesterase reactivators for antidotal treatment of nerve agent intoxication. Acta Medica (Hradec Kralove). 53: 207-211.
6. Bures J, Pejchal J, Kvetina J, Tichy A, Rejchrt S, Kunes M, et al (2011a). Morphometric analysis of the porcine gastrointestinal tract in a 10-day high-dose indomethacin administration with or without probiotic bacteria Escherichia coli Nissle 1917. Hum Exp Toxicol. 30: 1955-1962.
7. Bures J, Smajs D, Kvetina J, Forstl M, Smarda J, Kohoutova D, et al (2011b). Bacteriocinogeny in experimental pigs treated with indomethacin and Escherichia coli Nissle. World J Gastroenterol. 17: 609-617.
8. Chen JZ, McCallum RW, eds (1994). Electrogastrography. Principles and Applications. New York: Raven Press.
9. Explanatory Report on the European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes (ETS 123). Strasbourg: Council of Europe, 2009.
10. Goransson-Nyberg A, Cassel G, Jeneskog T, Karlsson L, Larsson R, Lundstrom M, et al (1995). Pharmacokinetics of HI-6 and atropine in anesthetized pigs after administration by a new autoinjector. Biopharm Drug Dist. 16: 915.1-915.17.
11. Hamilton MG, Lundy PM (1989). HI-6 therapy of soman and tabun poisoning in primates and rodents. Arch Toxicol. 63: 144-149. (Pubitemid 19107374)
12. Herkert NM, Freude G, Kunz U, Thiermann H, Worek F (2012). Comparative kinetics of organophosphates and oximes with erythrocyte, muscle and brain acetylcholinesterase. Toxicol Lett. 209: 173-178.
13. Jun D, Stodulka P, Kuca K, Koleckar V, Dolezal B, Simon P, et al (2008). TLC analysis of intermediates arising during the preparation of oxime HI-6 dimethanesulfonate. J Chrom Sci. 46: 316-319. (Pubitemid 351489532)
14. Jun D, Stodulka P, Kuca K, Dolezal B (2010). High-performance liquid chromatography analysis of by-products and intermediates arising during the synthesis of the acetylcholinesterase reactivator HI-6. J Chromatogr Sci. 48: 694-696.
15. Kararli TT (1995). Comparison of the gastrointestinal anatomy, physiology and biochemistry of humans and commonly used laboratory animals. Biopharm Drug Dispos. 16: 351-380.
16. Kassa J, Bajgar J, Kuca K, Musilek K, Karasova J (2008a). The present approaches to the development of prophylactic and therapeutic antidotes against nerve agents. Interdiscip Toxicol. 1: 18-21.
17. Kassa J, Karasova J, Musilek K, Kuca K (2008b). An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice. Toxicology. 243: 311-316. (Pubitemid 350256870)
18. Kassa J, Musilek K, Karasova JZ, Kuca K, Bajgar J (2012). Two possibilities how to increase the efficacy of antidotal treatment of nerve agent poisonings. Mini Rev Med Chem. 12: 24-34.
19. Kim TW, Koh SD, Ordög T, Ward SM, Sanders KM (2003). Muscarinic regulation of pacemaker frequency in murine gastric interstitial cells of Cajal. J Physiol. 546 (part 2): 415-425. (Pubitemid 36175977)
20. Koch KL, Stern RM (2004). Handbook of Electrogastrography. Oxford: Oxford University Press.
21. Kopacova M, Tacheci I, Kvetina J, Bures J, Kunes M, Spelda S, et al (2010). Wireless video capsule enteroscopy in preclinical studies: Methodical design of its applicability in experimental pigs. Dig Dis Sci. 55: 626-630.
22. Kuca K, Stodulka P, Hrabinova M, Hanusova P, Jun D, Dolezal B (2008) . Preparation of oxime HI-6 (dichloride and dimethane-sulphonate) - antidote against nerve agents. Defence Sci J. 58: 399-404.
23. Kuca K, Musilova L, Palecek J, Cirkva V, Paar M, Musilek K, et al (2009) . Novel bisquaternary oximes: reactivation of acetylcholinesterase and butyrylcholinesterase inhibited by paraoxon. Molecules. 14:4915-4921.
24. Kunes M, Kvetina J, Malakova J, Bures J, Kopacova M, Rejchrt S (2010). Pharmacokinetics and organ distribution of fluorescein in experimental pig: an input study for confocal laser endomicroscopy of the gastrointestinal tract. Neuroendocrinol Lett. 31: 57-61.
25. Kvetina J, Kunes M, Bures J, Kopacova M, Tacheci I, Spelda S (2008). The use of wireless capsule enteroscopy in a predinical study: a novel diagnostic tool for indomethacin-induced gastrointestinal injury in experimental pigs. Neuroendocrinol Lett. 29: 763-769.
26. Kvetina J, Varayil JE, Ali SM, Kunes M, Bures J, Tacheci I, et al (2010). Preclinical electrogastrography in experimental pigs. Interdiscip Toxicol. 3: 53-58.
27. Lundy PM, Tremblay K (1979). The ganglionic blocking properties of some bispyridinium soman antagonists. Eur J Pharmacol. 60:47-53. (Pubitemid 10168928)
28. Lundy PM, Hill I, Lecavalier P, Hamilton MG, Vair C, Davidson C, et al (2005). The pharmacokinetics and pharmacodynamics of two HI-6 salts in swine and efficacy in the treatment of GF and soman poisoning. Toxicology. 208: 399-409. (Pubitemid 40202838)
29. Lundy PM, Raveh L, Amitai G (2006). Development of the bis-quaternary oxime HI-6 toward clinical use in the treatment of organophosphate nerve agent poisoning. Toxicol Rev. 25: 231-243.
30. Parkman HP, Hasler WL, Barnett JL, Eaker EY (2003). Electrogastrography: a document prepared by the gastric section of the American Motility Society Clinical GI Motility Testing Task Force. Neurogastroenterol Motil. 15: 89-102. (Pubitemid 36532547)
31. Qiao GL, Williams PL, Riviere JE (1994). Percutaneous absorption, biotransformation, and systemic disposition of parathion in vivo in swine. I. Comprehensive pharmacokinetic model. Drug Metab Dispos. 22: 459-471. (Pubitemid 24158548)
32. Soukup O, Pohanka M, Tobin G, Jun D, Fusek J, Musilek K, et al (2008). The effect of HI-6 on cholinesterases and on the cholinergic system of the rat bladder. Neuroendocrinol Lett. 29: 759-762.
33. Suenderhauf C, Parrott N (2013). A physiologically based pharmacokinetic model of the minipig: data compilation and model implementation. Pharm Res. 30: 1-15.
34. Tacheci I, Kvetina J, Bures J, Osterreicher J, Kunes M, Pejchal J, et al (2010). Wireless capsule endoscopy in enteropathy induced by nonsteroidal anti-inflammatory drugs in pigs. Dig Dis Sci. 55: 2471-2477
35. Tacheci I, Kvetina J, Kunes M, Varayil JE, Ali SM, Pavlik M, et al (2011). Electrogastrography in experimental pigs: the influence of gastrointestinal injury induced by dextran sodium sulphate on porcine gastric erythromycin-stimulated myoelectric activity. Neuroendocrinol Lett. 32: 131-136.
36. Tacheci I, Kvetina J, Kunes M, Pavlik M, Kopacova M, Cerny V, et al (2013). The effect of general anaesthesia on gastric myoelectric activity in experimental pigs. BMC Gastroenterol. 13: 48.
37. van Helden HP, van der Wiel HJ, de Lange J, Busker RW, Melchers BP, Wolthuis OL (1992). Therapeutic efficacy of HI-6 in soman-poisoned marmoset monkeys. Toxicol Appl Pharmacol. 115: 50-56.
38. Varayil JE, Ali SM, Tacheci I, Kvetina J, Kopacova M, Kunes M, et al (2009). Electrogastrography in experimental pigs. Methodical design and initial experience. Folia Gastroenterol Hepatol. 7: 98-104. Available from: www.pro-folia.org.
39. Worek F, Aurbek N, Wetherell J, Pearce P, Mann T, Thiermann H (2008). Inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds: pig versus minipig acetylcholinesterase. Toxicology. 244: 35-41. (Pubitemid 350299080)
40. Worek F, Aurbek N, Wille T, Eyer P, Thiermann H (2011). Kinetic analysis of interactions of paraoxon and oximes with human, Rhesus monkey, swine, rabbit, rat and guinea pig acetylcholinesterase. Toxicol Lett. 200: 19-23.
41. Zdarova Karasova J, Zemek F, Kunes M, Kvetina J, Chladek J, et al (2013). Intravenous application of HI-6 salts (dichloride and dimethansulphonate) in pigs: Comparison with pharmacokinetics profile after intramuscular administration. Neuroendocrinol Lett. 34(Suppl. 2): xxx-xxx.